Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation

T. M. Suszynski, K. J. Gillingham, M. D. Rizzari, T. B. Dunn, W. D. Payne, S. Chinnakotla, E. B. Finger, D. E R Sutherland, J. S. Najarian, T. L. Pruett, A. J. Matas, R. Kandaswamy

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Rapid discontinuation of prednisone (RDP) has minimized steroid-related complications following kidney transplant (KT). This trial compares long-term (10-year) outcomes with three different maintenance immunosuppressive protocols following RDP in adult KT. Recipients (n = 440; 73% living donor) from March 2001 to April 2006 were randomized into one of three arms: cyclosporine (CSA) and mycophenolate mofetil (MMF) (CSA/MMF, n = 151); high-level tacrolimus (TAC, 8-12 μg/L) and low-level sirolimus (SIR, 3-7 μg/L) (TAC H/SIRL, n = 149) or low-level TAC (3-7 μg/L) and high-level SIR (8-12 μg/L) (TACL/SIRH, n = 140). Median follow-up was ∼7 years. There were no differences between arms in 10-year actuarial patient, graft and death-censored graft survival or in allograft function. There were no differences in the 10-year actuarial rates of biopsy-proven acute rejection (30%, 26% and 20% in CSA/MMF, TAC H/SIRL and TACL/SIRH) and chronic rejection (38%, 35% and 31% in CSA/MMF, TACH/SIRL and TACL/SIRH). Rates of new-onset diabetes mellitus were higher with TACH/SIRL (p = 0.04), and rates of anemia were higher with TACH/SIRL and TACL/SIRH (p = 0.04). No differences were found in the overall rates of 16 other post-KT complications. These data indicate that RDP-based protocol yield acceptable 10-year outcomes, but side effects differ based on the maintenance regimen used and should be considered when optimizing immunosuppression following RDP.

Original languageEnglish (US)
Pages (from-to)961-970
Number of pages10
JournalAmerican Journal of Transplantation
Volume13
Issue number4
DOIs
StatePublished - Apr 1 2013

Fingerprint

Mycophenolic Acid
Prednisone
Kidney Transplantation
Immunosuppression
Maintenance
Transplants
Kidney
Arm
Living Donors
Tacrolimus
Graft Survival
Sirolimus
Immunosuppressive Agents
Cyclosporine
Allografts
Anemia
Diabetes Mellitus
Steroids
Biopsy

Keywords

  • Kidney transplantation
  • rapid discontinuation of prednisone
  • steroid-free immunosuppression

Cite this

Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation. / Suszynski, T. M.; Gillingham, K. J.; Rizzari, M. D.; Dunn, T. B.; Payne, W. D.; Chinnakotla, S.; Finger, E. B.; Sutherland, D. E R; Najarian, J. S.; Pruett, T. L.; Matas, A. J.; Kandaswamy, R.

In: American Journal of Transplantation, Vol. 13, No. 4, 01.04.2013, p. 961-970.

Research output: Contribution to journalArticle

@article{51fc5e1d3ba148ff916de8d4e3bd0cec,
title = "Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation",
abstract = "Rapid discontinuation of prednisone (RDP) has minimized steroid-related complications following kidney transplant (KT). This trial compares long-term (10-year) outcomes with three different maintenance immunosuppressive protocols following RDP in adult KT. Recipients (n = 440; 73{\%} living donor) from March 2001 to April 2006 were randomized into one of three arms: cyclosporine (CSA) and mycophenolate mofetil (MMF) (CSA/MMF, n = 151); high-level tacrolimus (TAC, 8-12 μg/L) and low-level sirolimus (SIR, 3-7 μg/L) (TAC H/SIRL, n = 149) or low-level TAC (3-7 μg/L) and high-level SIR (8-12 μg/L) (TACL/SIRH, n = 140). Median follow-up was ∼7 years. There were no differences between arms in 10-year actuarial patient, graft and death-censored graft survival or in allograft function. There were no differences in the 10-year actuarial rates of biopsy-proven acute rejection (30{\%}, 26{\%} and 20{\%} in CSA/MMF, TAC H/SIRL and TACL/SIRH) and chronic rejection (38{\%}, 35{\%} and 31{\%} in CSA/MMF, TACH/SIRL and TACL/SIRH). Rates of new-onset diabetes mellitus were higher with TACH/SIRL (p = 0.04), and rates of anemia were higher with TACH/SIRL and TACL/SIRH (p = 0.04). No differences were found in the overall rates of 16 other post-KT complications. These data indicate that RDP-based protocol yield acceptable 10-year outcomes, but side effects differ based on the maintenance regimen used and should be considered when optimizing immunosuppression following RDP.",
keywords = "Kidney transplantation, rapid discontinuation of prednisone, steroid-free immunosuppression",
author = "Suszynski, {T. M.} and Gillingham, {K. J.} and Rizzari, {M. D.} and Dunn, {T. B.} and Payne, {W. D.} and S. Chinnakotla and Finger, {E. B.} and Sutherland, {D. E R} and Najarian, {J. S.} and Pruett, {T. L.} and Matas, {A. J.} and R. Kandaswamy",
year = "2013",
month = "4",
day = "1",
doi = "10.1111/ajt.12166",
language = "English (US)",
volume = "13",
pages = "961--970",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation

AU - Suszynski, T. M.

AU - Gillingham, K. J.

AU - Rizzari, M. D.

AU - Dunn, T. B.

AU - Payne, W. D.

AU - Chinnakotla, S.

AU - Finger, E. B.

AU - Sutherland, D. E R

AU - Najarian, J. S.

AU - Pruett, T. L.

AU - Matas, A. J.

AU - Kandaswamy, R.

PY - 2013/4/1

Y1 - 2013/4/1

N2 - Rapid discontinuation of prednisone (RDP) has minimized steroid-related complications following kidney transplant (KT). This trial compares long-term (10-year) outcomes with three different maintenance immunosuppressive protocols following RDP in adult KT. Recipients (n = 440; 73% living donor) from March 2001 to April 2006 were randomized into one of three arms: cyclosporine (CSA) and mycophenolate mofetil (MMF) (CSA/MMF, n = 151); high-level tacrolimus (TAC, 8-12 μg/L) and low-level sirolimus (SIR, 3-7 μg/L) (TAC H/SIRL, n = 149) or low-level TAC (3-7 μg/L) and high-level SIR (8-12 μg/L) (TACL/SIRH, n = 140). Median follow-up was ∼7 years. There were no differences between arms in 10-year actuarial patient, graft and death-censored graft survival or in allograft function. There were no differences in the 10-year actuarial rates of biopsy-proven acute rejection (30%, 26% and 20% in CSA/MMF, TAC H/SIRL and TACL/SIRH) and chronic rejection (38%, 35% and 31% in CSA/MMF, TACH/SIRL and TACL/SIRH). Rates of new-onset diabetes mellitus were higher with TACH/SIRL (p = 0.04), and rates of anemia were higher with TACH/SIRL and TACL/SIRH (p = 0.04). No differences were found in the overall rates of 16 other post-KT complications. These data indicate that RDP-based protocol yield acceptable 10-year outcomes, but side effects differ based on the maintenance regimen used and should be considered when optimizing immunosuppression following RDP.

AB - Rapid discontinuation of prednisone (RDP) has minimized steroid-related complications following kidney transplant (KT). This trial compares long-term (10-year) outcomes with three different maintenance immunosuppressive protocols following RDP in adult KT. Recipients (n = 440; 73% living donor) from March 2001 to April 2006 were randomized into one of three arms: cyclosporine (CSA) and mycophenolate mofetil (MMF) (CSA/MMF, n = 151); high-level tacrolimus (TAC, 8-12 μg/L) and low-level sirolimus (SIR, 3-7 μg/L) (TAC H/SIRL, n = 149) or low-level TAC (3-7 μg/L) and high-level SIR (8-12 μg/L) (TACL/SIRH, n = 140). Median follow-up was ∼7 years. There were no differences between arms in 10-year actuarial patient, graft and death-censored graft survival or in allograft function. There were no differences in the 10-year actuarial rates of biopsy-proven acute rejection (30%, 26% and 20% in CSA/MMF, TAC H/SIRL and TACL/SIRH) and chronic rejection (38%, 35% and 31% in CSA/MMF, TACH/SIRL and TACL/SIRH). Rates of new-onset diabetes mellitus were higher with TACH/SIRL (p = 0.04), and rates of anemia were higher with TACH/SIRL and TACL/SIRH (p = 0.04). No differences were found in the overall rates of 16 other post-KT complications. These data indicate that RDP-based protocol yield acceptable 10-year outcomes, but side effects differ based on the maintenance regimen used and should be considered when optimizing immunosuppression following RDP.

KW - Kidney transplantation

KW - rapid discontinuation of prednisone

KW - steroid-free immunosuppression

UR - http://www.scopus.com/inward/record.url?scp=84875740309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875740309&partnerID=8YFLogxK

U2 - 10.1111/ajt.12166

DO - 10.1111/ajt.12166

M3 - Article

VL - 13

SP - 961

EP - 970

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 4

ER -